Gonococcal (GC) Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Gonococcal (GC) Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06897943

Epidemiology of Gonococcal Arthritis (EpGAr)

The aim of this retrospective observational study was to describe the epidemiology of Neisseria gonorrhoeae septic arthritis over the last 10 years at Brest and…

France11 participantsStarted 2024-12-01

All recent trials (4 shown)

TerminatedPhase 2/3

NCT03632109

Gent for Pharyngeal Gonorrhea (GC)

The Centers for Disease Control and Prevention has identified antimicrobial-resistant (AMR) Neisseria gonorrhoeae (NG) as one of the nation's top three urgent A…

United States13 participantsStarted 2018-09-17

Treatment: gentamicin 360mg IM

TerminatedNot Applicable

NCT01167777

Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae

Multicenter clinical study to test a new qualitative in vitro nucleic acid amplification assay based on kPCR technology. The assay is intended for the diagnosis…

United States2,296 participantsStarted 2010-08

Gonococcal (GC) Infection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Epidemiology of Gonococcal Arthritis (EpGAr)

All recent trials (4 shown)

Gent for Pharyngeal Gonorrhea (GC)

Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Epidemiology of Gonococcal Arthritis (EpGAr)

All recent trials (4 shown)

Gent for Pharyngeal Gonorrhea (GC)

Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914